![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 31, 21817-21822, July 30, 1999
,
,
,
, and
From the Mutations in the genes that code for collagen VI
subunits, COL6A1, COL6A2, and
COL6A3, are the cause of the autosomal dominant disorder,
Bethlem myopathy. Although three different collagen VI structural
mutations have previously been reported, the effect of these mutations
on collagen VI assembly, structure, and function is currently unknown.
We have characterized a new Bethlem myopathy mutation that results in
skipping of COL6A1 exon 14 during pre-mRNA splicing and
the deletion of 18 amino acids from the triple helical domain of the
Orthopaedic Molecular Biology Research Unit,
Department of Paediatrics, University of Melbourne, Royal Children's
Hospital, Parkville, Victoria 3052, Australia and the ¶ Department
of Paediatrics,
Department of
Neurology,
1(VI) chain. Sequencing of genomic DNA identified a G to A
transition in the +1 position of the splice donor site of intron 14 in
one allele. The mutant
1(VI) chains associated intracellularly with
2(VI) and
3(VI) to form disulfide-bonded monomers, but further
assembly into dimers and tetramers was prevented, and molecules
containing the mutant chain were not secreted. This triple helical
deletion thus resulted in production of half the normal amount of
collagen VI. To further explore the biosynthetic consequences of
collagen VI triple helical deletions, an
3(VI) cDNA expression
construct containing a 202-amino acid deletion within the triple helix
was produced and stably expressed in SaOS-2 cells. The transfected
mutant
3(VI) chains associated with endogenous
1(VI) and
2(VI)
to form collagen VI monomers, but dimers and tetramers did not form and
the mutant-containing molecules were not secreted. Thus, deletions
within the triple helical region of both the
1(VI) and
3(VI)
chains can prevent intracellular dimer and tetramer assembly and
secretion. These results provide the first evidence of the biosynthetic
consequences of structural collagen VI mutations and suggest that
functional protein haploinsufficiency may be a common pathogenic
mechanism in Bethlem myopathy.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
J. Fitzgerald, C. Rich, F. H. Zhou, and U. Hansen Three Novel Collagen VI Chains, {alpha}4(VI), {alpha}5(VI), and {alpha}6(VI) J. Biol. Chem., July 18, 2008; 283(29): 20170 - 20180. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lamande, M. Morgelin, N. E. Adams, C. Selan, and J. M. Allen The C5 Domain of the Collagen VI {alpha}3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells J. Biol. Chem., June 16, 2006; 281(24): 16607 - 16614. [Abstract] [Full Text] [PDF] |
||||
![]() |
A K Lampe and K M D Bushby Collagen VI related muscle disorders J. Med. Genet., September 1, 2005; 42(9): 673 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lucioli, B. Giusti, E. Mercuri, O. C. Vanegas, L. Lucarini, V. Pietroni, A. Urtizberea, R. B. Yaou, M. de Visser, A. J. van der Kooi, et al. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy Neurology, June 14, 2005; 64(11): 1931 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A K Lampe, D M Dunn, A C von Niederhausern, C Hamil, A Aoyagi, S H Laval, S K Marie, M-L Chu, K Swoboda, F Muntoni, et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy J. Med. Genet., February 1, 2005; 42(2): 108 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Baker, M. Morgelin, R. Peat, N. Goemans, K. N. North, J. F. Bateman, and S. R. Lamande Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy Hum. Mol. Genet., January 15, 2005; 14(2): 279 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wiberg, D. Heinegard, C. Wenglen, R. Timpl, and M. Morgelin Biglycan Organizes Collagen VI into Hexagonal-like Networks Resembling Tissue Structures J. Biol. Chem., December 13, 2002; 277(51): 49120 - 49126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Z. Zhang, P. Sabatelli, T.-C. Pan, S. Squarzoni, E. Mattioli, E. Bertini, G. Pepe, and M.-L. Chu Effects on Collagen VI mRNA Stability and Microfibrillar Assembly of Three COL6A2 Mutations in Two Families with Ullrich Congenital Muscular Dystrophy J. Biol. Chem., November 8, 2002; 277(46): 43557 - 43564. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Scacheri, E. M. Gillanders, S. H. Subramony, V. Vedanarayanan, C. A. Crowe, N. Thakore, M. Bingler, and E. P. Hoffman Novel mutations in collagen VI genes: Expansion of the Bethlem myopathy phenotype Neurology, February 26, 2002; 58(4): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Vanegas, E. Bertini, R.-Z. Zhang, S. Petrini, C. Minosse, P. Sabatelli, B. Giusti, M.-L. Chu, and G. Pepe Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI PNAS, May 24, 2001; (2001) 121027598. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fitzgerald, M. Morgelin, C. Selan, C. Wiberg, D. R. Keene, S. R. Lamande, and J. F. Bateman The N-terminal N5 Subdomain of the alpha 3(VI) Chain Is Important for Collagen VI Microfibril Formation J. Biol. Chem., January 5, 2001; 276(1): 187 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wiberg, E. Hedbom, A. Khairullina, S. R. Lamande, A. Oldberg, R. Timpl, M. Morgelin, and D. Heinegard Biglycan and Decorin Bind Close to the N-terminal Region of the Collagen VI Triple Helix J. Biol. Chem., May 25, 2001; 276(22): 18947 - 18952. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lamande, M. Morgelin, C. Selan, G. J. Jobsis, F. Baas, and J. F. Bateman Kinked Collagen VI Tetramers and Reduced Microfibril Formation as a Result of Bethlem Myopathy and Introduced Triple Helical Glycine Mutations J. Biol. Chem., January 11, 2002; 277(3): 1949 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Camacho Vanegas, E. Bertini, R.-Z. Zhang, S. Petrini, C. Minosse, P. Sabatelli, B. Giusti, M.-L. Chu, and G. Pepe Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI PNAS, June 19, 2001; 98(13): 7516 - 7521. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |